251 related articles for article (PubMed ID: 23174220)
1. Monogalactosyl diacylglycerol, a replicative DNA polymerase inhibitor, from spinach enhances the anti-cell proliferation effect of gemcitabine in human pancreatic cancer cells.
Akasaka H; Sasaki R; Yoshida K; Takayama I; Yamaguchi T; Yoshida H; Mizushina Y
Biochim Biophys Acta; 2013 Mar; 1830(3):2517-25. PubMed ID: 23174220
[TBL] [Abstract][Full Text] [Related]
2. Structure and activity relationship of monogalactosyl diacylglycerols, which selectively inhibited in vitro mammalian replicative DNA polymerase activity and human cancer cell growth.
Matsui Y; Hada T; Maeda N; Sato Y; Yamaguchi Y; Takeuchi T; Takemura M; Sugawara F; Sakaguchi K; Yoshida H; Mizushina Y
Cancer Lett; 2009 Sep; 283(1):101-7. PubMed ID: 19376642
[TBL] [Abstract][Full Text] [Related]
3. MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells.
Akasaka H; Mizushina Y; Yoshida K; Ejima Y; Mukumoto N; Wang T; Inubushi S; Nakayama M; Wakahara Y; Sasaki R
Radiat Oncol; 2016 Nov; 11(1):153. PubMed ID: 27876069
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect on replicative DNA polymerases, human cancer cell proliferation, and in vivo anti-tumor activity by glycolipids from spinach.
Maeda N; Hada T; Yoshida H; Mizushina Y
Curr Med Chem; 2007; 14(9):955-67. PubMed ID: 17439396
[TBL] [Abstract][Full Text] [Related]
5. Effects of glycolipids from spinach on mammalian DNA polymerases.
Murakami C; Kumagai T; Hada T; Kanekazu U; Nakazawa S; Kamisuki S; Maeda N; Xu X; Yoshida H; Sugawara F; Sakaguchi K; Mizushina Y
Biochem Pharmacol; 2003 Jan; 65(2):259-67. PubMed ID: 12504801
[TBL] [Abstract][Full Text] [Related]
6. In vivo antitumor effect of liposomes with sialyl Lewis X including monogalactosyl diacylglycerol, a replicative DNA polymerase inhibitor, from spinach.
Mizushina Y; Hada T; Yoshida H
Oncol Rep; 2012 Sep; 28(3):821-8. PubMed ID: 22767329
[TBL] [Abstract][Full Text] [Related]
7. Quercetin induces apoptosis and enhances gemcitabine therapeutic efficacy against gemcitabine-resistant cancer cells.
Liu ZJ; Xu W; Han J; Liu QY; Gao LF; Wang XH; Li XL
Anticancer Drugs; 2020 Aug; 31(7):684-692. PubMed ID: 32282368
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects of the glycolipids fraction from spinach which inhibited DNA polymerase activity.
Maeda N; Kokai Y; Ohtani S; Sahara H; Hada T; Ishimaru C; Kuriyama I; Yonezawa Y; Iijima H; Yoshida H; Sato N; Mizushina Y
Nutr Cancer; 2007; 57(2):216-23. PubMed ID: 17571956
[TBL] [Abstract][Full Text] [Related]
9. Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.
Singla S; Pippin JA; Drebin JA
Oncol Rep; 2012 Dec; 28(6):2211-6. PubMed ID: 23007710
[TBL] [Abstract][Full Text] [Related]
10. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
[TBL] [Abstract][Full Text] [Related]
11. S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway.
Liu Y; Bi T; Liu L; Gao Q; Shen G; Qin L
Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):615-622. PubMed ID: 30683944
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells.
Jacob DA; Bahra M; Langrehr JM; Boas-Knoop S; Stefaniak R; Davis J; Schumacher G; Lippert S; Neumann UP
J Gastroenterol Hepatol; 2007 May; 22(5):738-48. PubMed ID: 17444865
[TBL] [Abstract][Full Text] [Related]
13. The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX.
Wang Y; Kuramitsu Y; Kitagawa T; Tokuda K; Baron B; Akada J; Nakamura K
Target Oncol; 2015 Dec; 10(4):575-81. PubMed ID: 25940934
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures.
Daunys S; Matulis D; Petrikaitė V
Sci Rep; 2019 Nov; 9(1):16177. PubMed ID: 31700053
[TBL] [Abstract][Full Text] [Related]
15. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
Shi Y; Wang Y; Qian J; Yan X; Han Y; Yao N; Ma J
Life Sci; 2020 Oct; 259():118148. PubMed ID: 32721465
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira.
Yu J; Drisko J; Chen Q
Oncol Rep; 2013 Jul; 30(1):149-56. PubMed ID: 23674070
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of monogalactosyldiacylglycerol, extracted from spinach using supercritical CO2, on mammalian DNA polymerase activity.
Iijima H; Musumi K; Hada T; Maeda N; Yonezawa Y; Yoshida H; Mizushina Y
J Agric Food Chem; 2006 Mar; 54(5):1627-32. PubMed ID: 16506811
[TBL] [Abstract][Full Text] [Related]
18. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
[TBL] [Abstract][Full Text] [Related]
20. (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells.
Wu P; Wang X; Ma Y; Xu X; Liu W; Sheng Z; Chen M; Zhou R; Zhang K; Goodin S; Zheng X; Li D
Bioorg Chem; 2020 Aug; 101():104022. PubMed ID: 32599367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
